Popular Articles

Major Head, Neck And Shoulder Pain Study Targets Region With Nearly Five Million Inhabitants
Researchers at the University of Turin have launched a major initiative to prevent and
generic viagra online
Pharmacy Bodies Work Together To Promote The Integration Of Pharmacy Within Lord Darzi's Primary & Community Care Strategy
"Maximising Health Gain Through Community Pharmacy" is the title of two jointly badged publications from pharmacy organisations CCA, NPA, RPSGB, PSNC and AIMp. The documents, which were produced in collaboration with the NHS Alliance, were launched to the NHS this week, as part of a strategy to promote the role of pharmacists to commissioners, managers, general practitioners and others in primary care. The documents also seek to influence the commissioning of pharmacy services by PCTs under World Class Commissioning and the integration of pharmacy into Practice Based Commissioning (PBC).
News of the day
St. Jude Medical Announces Australian TGA Regulatory Approval For Libra Deep Brain Stimulation Systems For Parkinson's Disease
St. Jude Medical, Inc. (NYSE:STJ) announced Australian Therapeutic Goods Administration (TGA) approval of its Libra® and LibraXP™ deep brain stimulation (DBS) systems for treating the symptoms of Parkinson"s disease, a neurological disorder that progressively diminishes a person"s control over his or her movements.
Cardiovascular

In A Chemical Library, Yale Researchers Find Keys To Cell Movement

Rummaging through a biotechnology company"s chemical closet, Yale University researchers found two molecules that will allow scientists to better study how cells move. The study in the journal Nature, published online Aug. 2, describes how two small molecules discovered by Cytokinetics Inc. block the action of a key complex that directs the assembly of actin filaments, which produce the force to help cells move. The target of these inhibitors is the Arp2/3 complex, a cellular component so vital that cells die without it. This dependence has made it challenging to learn exactly which cellular processes depend upon the complex. Thomas Pollard, senior author the study and Sterling Professor of Molecular, Cellular & Developmental Biology, said that the inhibitors will allow scientists to turn the complex off and on, helping shed light on the mechanism of cell movement. Pollard noted that cell biologists "desperately need these tools to switch Arp2/3 complex off reversibly without killing the cells." These inhibitors should help scientists determine how nerve cells grow processes to wire the nervous system, embryonic cells migrate to form organs and white blood cells find bacteria. Although the molecules were not useful to Cytokinetics as drug candidates, they are of great scientific interest to biological researchers who study the movement of cells. Pollard"s team determined the crystal structures showing where both of the molecules lodge to block the action of Arp2/3 complex. Pollard serves on the Scientific Advisory Board of Cytokinetics, which found the inhibitors and collaborated on the project. Other Yale authors on the paper include Bradley Nolen, the co-lead author, and CD McCormick. Cytokinetics Inc. and the National Institutes of Health funded the study. Link: Thomas D. Pollard Yale University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):